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ANNOUNCEMENT 
The 9th Annual Meeting of the Skin Pharmacology Society will be held October 14-16,1992 
at the Stouffer Tower City Plaza Hotel in Cleveland, Ohio. There will be a special symposium 
on neuroendocrine immunologic interactions in skin, on novel phototherapies, and on clinical 
research, and the Albert Kligman Lecture will be presented October 16. There will be an 
opportunity for free oral and poster communications. The closing date for submission of 
abstracts is May 15, 1992. Abstract forms and meeting registration information can be obtained 
by writing to Pauline M Dowd, MD, FRCP, Secretary jTreasurer-S.P.S., Department of Der-
matology, Middlesex Hospital, Mortimer Street, London W1N 8AA. 
